Epicardial Adipose Tissue Composition and Heart Failure With Preserved Ejection Fraction

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 192 participants.

Also called NCT07178145

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose diagnostic
Phase
Phase 4
Enrolled
  • 192 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07178145
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07178145. Non-randomized; no masking; primary purpose diagnostic. Start 2025-11-20 (actual); primary completion 2029-09 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Epicardial Adipose Tissue Composition and Heart Failure With Preserved Ejection Fraction
Condition
Heart Failure Preserved Ejection Fraction
Condition
Epicardial Adipose Tissue
Intervention (Drug)
GLP-1RA
Lead sponsor
University of Virginia (class: other)
Collaborator
National Institutes of Health (NIH) (class: US National Institutes of Health)

Record details

Record id
cardio:ct-nct07178145
Content hash
a5330d1add4928677c69fced27870c88fdf1fa1fcca21c2d2f1889610ca527ab